medroxyprogesterone acetate has been researched along with Neutropenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aydin, F; Ovali, E; Sonmez, M; Ulusoy, S | 1 |
| Akbulut, H; Aydin, F; Demirkazik, A; Içli, F; Samur, M | 1 |
2 trial(s) available for medroxyprogesterone acetate and Neutropenia
| Article | Year |
|---|---|
Effect of high-dose medroxyprogesterone acetate on tumor necrosis factor-alpha release in patients with chemotherapy-induced neutropenia.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Female; Hematocrit; Humans; Leukocyte Count; Male; Medroxyprogesterone Acetate; Middle Aged; Neutropenia; Neutrophils; Platelet Count; Tumor Necrosis Factor-alpha | 1997 |
Effects of high dose medroxyprogesterone acetate on endogenous granulocyte macrophage-colony stimulating factor secretion and bone marrow cellularity in patients under cytotoxic chemotherapy.
Topics: Adult; Aged; Antigens, CD34; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Cell Division; Dose-Response Relationship, Drug; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Interleukin-3; Male; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Neutropenia | 1998 |